These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4060364)

  • 41. Quantitative determination of methylated nucleosides and pseudouridine in urine by gas-liquid chromatography.
    Chang SY; Lakings DB; Zumwalt RW; Gehrke CW; Waalkes TP
    J Lab Clin Med; 1974 May; 83(5):816-30. PubMed ID: 4821860
    [No Abstract]   [Full Text] [Related]  

  • 42. An enzyme-linked immunosorbent assay (ELISA) for the detection and quantitation of the tumor marker 1-methylinosine in human urine.
    D'Ambrosio SM; Gibson-D'Ambrosio RE; Trewyn RW
    Clin Chim Acta; 1991 Jun; 199(2):119-28. PubMed ID: 1873911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary excretion of nucleosides varies with age and protein metabolism.
    Prankel BH; Clemens PC; Burmester JG
    Clin Chim Acta; 1995 Jan; 234(1-2):181-3. PubMed ID: 7758219
    [No Abstract]   [Full Text] [Related]  

  • 44. Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.
    Dulong S; Huang Q; Innominato PF; Karaboue A; Bouchahda M; Pruvost A; Théodoro F; Agrofoglio LA; Adam R; Finkenstädt B; Lévi F
    Sci Rep; 2021 Dec; 11(1):24015. PubMed ID: 34907230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
    Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.
    Mao Y; Zhao X; Wang S; Cheng Y
    Anal Chim Acta; 2007 Aug; 598(1):34-40. PubMed ID: 17693304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urinary excretion of pseudouridine in patients with brain tumours.
    Manjula S; Aroor AR; Raja A; Rao S; Rao A
    Acta Oncol; 1993; 32(3):311-4. PubMed ID: 8323769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
    Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
    Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
    Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body.
    Sander G; Topp H; Wieland J; Heller-Schöch G; Schöch G
    Hum Nutr Clin Nutr; 1986 Mar; 40(2):103-18. PubMed ID: 2420752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
    Mrochek JE; Dinsmore SR; Waalkes TP
    J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
    [No Abstract]   [Full Text] [Related]  

  • 54. [The studies of natural killer cell activity in uro-genital cancer patients--investigation of natural killer cell activity from the standpoint of stage and antitumor therapy of genito-urinary tract carcinomas].
    Fukasawa K
    Nihon Hinyokika Gakkai Zasshi; 1988 Feb; 79(2):239-45. PubMed ID: 3226000
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on the clinical significance of nonesterified and total cholesterol in urine.
    Jüngst D; Wallner J; Pickel A; Stadler A; Eiermann W; Marx FJ; Karl HJ
    Klin Wochenschr; 1981 Jun; 59(11):545-52. PubMed ID: 6167760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma.
    Rasmuson T; Björk GR; Hietala SO; Stenling R; Ljungberg B
    Acta Oncol; 1991; 30(1):11-5. PubMed ID: 2009178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Selective characterisation of N1-methyladenosine and N7-methylguanosine in urine (author's transl)].
    Schlimme E; Boos KS; Weise M
    J Clin Chem Clin Biochem; 1981 Feb; 19(2):55-60. PubMed ID: 7217895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients.
    Vold BS; Keith DE; Slavik M
    Cancer Res; 1982 Dec; 42(12):5265-9. PubMed ID: 7139629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development, validation and application of a fast analytical methodology for the simultaneous determination of DNA- and RNA-derived urinary nucleosides by liquid chromatography coupled to tandem mass spectrometry.
    Rodríguez-Gonzalo E; Herrero-Herrero L; García-Gómez D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():132-9. PubMed ID: 26565068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serum 1-methyladenosine and pseudouridine as tumor markers in tumor-bearing mice].
    Ishiwata S; Itoh K; Yamaguchi T; Sasaki S; Ishida N; Mizugaki M
    Yakugaku Zasshi; 1995 Jul; 115(7):523-7. PubMed ID: 7562399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.